溶解性細菌菌vB_EhoP_ZX13の特徴と,Enterobacter hormaechei感染に対するその治療的可能性
Yilin Liu1, Shuang Liang1, Jincheng Zhang1
1College of Veterinary Medicine, Institute of Comparative Medicine, Yangzhou University, Yangzhou 225009, China.
Research in veterinary science
|August 24, 2025
まとめ
新型細菌菌であるvB_EhoP_ZX13は,多剤耐性であるEnterobacter hormaecheiの感染をin vitroおよびin vivoで効果的に抵抗する. このリチスファージは,動物疾患に対する安全で効果的な代替治療戦略として有望である.
科学分野:
- 微生物学とウイルス学
- 動物の健康と病気
- 抗菌剤に対する耐性
背景:
- Enterobacter hormaecheiは様々な動物病を引き起こす機会性病原体です.
- E. hormaecheiの多剤耐性には新しい治療方法が必要である.
- バクテリオファージ治療は 抗生物質の有望な代替手段です
研究 の 目的:
- E. hormaecheiに対するリチ菌体を分離し,特徴づけること.
- 隔離されたファグの治療の可能性を in vitro と in vivo で評価する.
- 細菌菌の生物安全性を評価し,臨床応用の可能性を明らかにする.
主な方法:
- バクテリオファージvB_EhoP_ZX13の分離と形態学的特徴づけ
- 最適な感染条件 (MOI,温度,pH) の決定
- ウイルス性,リソゲン性,耐性遺伝子を特定するためのゲノム分析.
- In vitro 成長抑制試験と in vivo マウス感染モデル
主要な成果:
- vB_EhoP_ZX13は,長尾のファグ (ストラボウイルス科) で,高解毒活性を示した.
- 最適な感染はMOI 1で,潜伏期間は5分,細胞爆発サイズは100PFUです.
- ファグゲノム (172,900 bp dsDNA) には毒性,溶解性,または抗生物質耐性遺伝子が欠けている.
- 感染したマウスの90%の生存率.
結論:
- vB_EhoP_ZX13は,E. hormaecheiに対する強力なリチ菌体です.
- このファージは安定性や生物学的安全性を有する.
- vB_EhoP_ZX13は,E. hormaecheiの感染に対する代替治療薬として重要な可能性を秘めています.
関連する概念動画
01:30Lytic Cycle of Bacteriophages
71.9K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.9K
01:20Viral Replication: Lytic Cycle
243
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
243
00:43Lysogenic Cycle of Bacteriophages
63.2K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
63.2K
01:16Viral Replication: Lysogenic Cycle
230
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
230
01:26DNA Bacteriophages
143
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
143